Corporate Europe Observatory

Exposing the power of corporate lobbying in the EU

EU research funding: for whose benefit?

  • Dansk
  • Nederlands
  • English
  • Français
  • Deutsch
  • Ελληνικά
  • Italiano
  • Portuguese
  • Español
Printer-friendly versionSend by emailPDF version

The European Union's multi-billion research funding programme is supposed to help society meet the grand challenges it faces. But there is concern that the participation of large corporations is skewing research agendas towards narrow interest, and leading to the substitution of public for private funding. Will the EU's new Research Program, Horizon 2020, avoid these pitfalls?

 

Similar entries

Corporate world has too much power over R&D funding

Comment piece published in Public Service Europe on December 8 2011.

Companies Reap EU Research Rewards

Millions of euros of EU research money is being directed towards controversial projects which do not benefit the public interest, according to new research from Corporate Europe Observatory published today [1].

The report, which is launched as the European Commission hosts a conference on research in Brussels [2], says that the approval of so-many controversial projects is not surprising, given that many of the companies were also involved in writing the EU’s Strategic Research Agenda, which sets the priorities for new research.

Agrofuels and the EU Research Budget

Despite well-publicised concerns about the damaging social and environmental impacts of large-scale agrofuel production, the European Union continues to provide incentives to promote their development, including through public funding for research. This article highlights how industry is now benefiting from research funding, having helped the EU write its Strategic Research Agenda, setting the criteria for research.

Secret funding for climate deniers

Brussels, 7 December 2010 – Funding for the European think tanks promoting denialist views on the science of climate change remains clouded in secrecy, a new investigation by Corporate Europe Observatory (CEO) published today has revealed [1].

Biotech lobby targets the EU's research and agriculture funds

Late in the afternoon of 31st May, on the 7th floor in the European Parliament in Brussels, the biotech lobby group EuropaBio organised a lobbying event on “The Bioeconomy for Europe – Innovating for Sustainability”. The meeting was chaired by the right-wing Finnish MEP Sirpa Pietikäinen (EPP). The audience was mostly composed of Commission officials, MEP assistants and EuropaBio members.

Pages

No. Ireland, Vote for us on 31st of May

Corporate Europe Observatory

Corporate Europe Observatory (CEO) is a research and campaign group working to expose and challenge the privileged access and influence enjoyed by corporations and their lobby groups in EU policy making.

Read more